Janel Nuzum
Psychiatric/Mental Health · Parkersburg, WVNPI 1437563558
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.5% of the total across 219 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AbbVie at 25.1% of the total. Reporting peaked in 2023 at $1,048 and has fallen 63.1% since, to $387 in 2025. Among psychiatric/mental health clinicians in WV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 219 payments — averaging $15.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$834
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$568
- Corium, LLC$359
- Ironshore Pharmaceuticals Inc.$218
- Takeda Pharmaceuticals U.S.A., Inc.$176
- Collegium Pharmaceutical, Inc.$163
- plus $1K from 21 others
What the payments were for
- Food & beverage$3,26999%
- Education$491%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$3,318 in reported general payments places this provider in the 90th percentile of 142 psychiatric/mental health providers in West Virginia.
See all psychiatric/mental health providers in West Virginia →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NuedextaDextromethorphan Hbr/Quinidine | 12 | $18,025 |
| Clozapine | 12 | $1,256 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 26 | $1,166 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 20 | $450 |
| Dexmethylphenidate Hcl | 22 | $345 |
| Escitalopram Oxalate | 11 | $164 |
| Mirtazapine | 14 | $159 |
| Clonazepam | 31 | $71 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Avanir Pharmaceuticals, Inc.Nuedexta | $57 | $18,02512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 142 psychiatric/mental health providers in West Virginia.
Other psychiatric/mental health in Parkersburg
- Kimberly RittenhouseParkersburg$7K
- Summer DevolParkersburg$5K
- Cathy McGeeParkersburg$4K
- Britney OhseParkersburg$3K
- Angela MonroeParkersburg$3K
- Megan RadcliffParkersburg$2K
- Tiffani WaltersParkersburg$2K
- Ivy LingerParkersburg$1K
- Brittany KingParkersburg$1K
- Melanie Vogt-MccloyParkersburg$924
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.